Improved Production and Characterization of Recombinant Human Granulocyte Colony Stimulating Factor from E. coli under Optimized Downstream Processes.

This work reports the upstream and downstream process of recombinant human granulocyte colony stimulating factor (rhG-CSF) expressed in Escherichia coli BL21 (DE3)pLysS. The fed batch mode was selected for the maximum output of biomass (6.4g/L) and purified rhG-CSF (136mg/L) under suitable physicochemical environment. The downstream processing steps viz., recovery, solubilization, refolding and concentration were optimized in this study. The maximum rhG-CSF inclusion bodies recovery yield (97%) was accomplished with frequent homogenization and sonication procedure. An efficient solubilization (96%) of rhG-CSF inclusion bodies were observed with 8M urea at pH 9.5. Refolding efficiency studies showed maximum refolding ⩾86% and ⩾84% at 20°C and pH 9 respectively. The renatured protein solution was concentrated, clarified and partially purified (⩾95%) by the cross flow filtration technique. The concentrated protein was further purified by a single step size exclusion chromatography with ⩾98% purity. The characterization of purified rhG-CSF molecular mass as evidenced by SDS-PAGE, western blot and LC/MS analysis was shown to be 18.8kDa. The secondary structure of rhG-CSF was evaluated by the CD spectroscopic technique based on the helical structural components. The biological activity of the purified rhG-CSF showed a similar activity of cell proliferation with the standard rhG-CSF. Overall, the results demonstrate an optimized downstream process for obtaining high yields of biologically active rhG-CSF.

[1]  M. Marín,et al.  Mini Review Article , 2022 .

[2]  Masaya Miyazaki,et al.  Refolding Techniques for Recovering Biologically Active Recombinant Proteins from Inclusion Bodies , 2014, Biomolecules.

[3]  P. Ho,et al.  Expression of recombinant human mutant granulocyte colony stimulating factor (Nartograstim) in Escherichia coli , 2012, World Journal of Microbiology and Biotechnology.

[4]  Houming Wu,et al.  Highly Efficient Production of Soluble Proteins from Insoluble Inclusion Bodies by a Two-Step-Denaturing and Refolding Method , 2011, PloS one.

[5]  M. L. Narasu,et al.  Impact of dissolved oxygen concentration on some key parameters and production of rhG-CSF in batch fermentation , 2008, Journal of Industrial Microbiology & Biotechnology.

[6]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[7]  Nien-Hwa Linda Wang,et al.  Phenomena of insulin peak fronting in size exclusion chromatography and strategies to reduce fronting. , 2008, Journal of chromatography. A.

[8]  D. Ejima,et al.  Aggregation Analysis of Therapeutic Proteins , Part 1 General Aspects and Techniques for Assessment , 2006 .

[9]  R. Bowsher,et al.  Application of size-exclusion chromatography in the investigation of the in vitro stability of proinsulin and its cleaved metabolites in human serum and plasma. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  Shoei-Shen Wang,et al.  Effect of Glutathione Redox System on Lysozyme Refolding in Size Exclusion Chromatography , 2006 .

[11]  L. Narhi,et al.  Folding and oxidation of recombinant human granulocyte colony stimulating factor produced in Escherichia coli. Characterization of the disulfide-reduced intermediates and cysteine----serine analogs. , 1992, The Journal of biological chemistry.

[12]  Chaozhan Wang,et al.  Refolding and purification of recombinant human granulocyte colony-stimulating factor using hydrophobic interaction chromatography at a large scale , 2012 .

[13]  H. Gilbert.  Protein chaperones and protein folding. , 1994, Current opinion in biotechnology.

[14]  S. Millard,et al.  Dscam-mediated cell recognition regulates neural circuit formation. , 2008, Annual Review of Cell and Developmental Biology.

[15]  G. Nilsson,et al.  Distinct and regulated expression of Notch receptors in hematopoietic lineages and during myeloid differentiation , 2001, European journal of immunology.

[16]  R. Burgess.  Refolding solubilized inclusion body proteins. , 2009, Methods in enzymology.

[17]  A. Ward,et al.  G-CSF: function and modes of action (Review). , 2002, International journal of molecular medicine.

[18]  F. Regnier,et al.  Nonideal size-exclusion chromatography of proteins: effects of pH at low ionic strength. , 1982, Analytical biochemistry.

[19]  S. Asano,et al.  Adhesion of NFS-60 myeloid leukemia cells to MC3T3-G2/PA6 stromal cells induces granulocyte colony-stimulating factor production. , 1994, Blood.

[20]  Lili Wang,et al.  Optimization of refolding with simultaneous purification of recombinant human granulocyte colony-stimulating factor from Escherichia coli by immobilized metal ion affinity chromatography , 2009 .

[21]  P. Klesius,et al.  Chemical and electroporated transformation of Edwardsiella ictaluri using three different plasmids. , 2009, FEMS microbiology letters.

[22]  Ursula Rinas,et al.  Microbial Cell Factories BioMed Central Review , 2003 .

[23]  E. Selvarajan,et al.  Purification of human recombinant granulocyte colony stimulating factor from Escherichia coli , 2012 .

[24]  W. Jiskoot,et al.  Elution behavior of insulin on high-performance size exclusion chromatography at neutral pH. , 2010, Journal of pharmaceutical and biomedical analysis.

[25]  R. Burgess,et al.  Using Disulfide Bond Engineering To Study Conformational Changes in the β′260-309 Coiled-Coil Region of Escherichia coli RNA Polymerase during σ70 Binding , 2002, Journal of bacteriology.

[26]  Chaozhan Wang,et al.  Renaturation of Recombinant Human Granulocyte Colony‐Stimulating Factor Produced from Escherichia coli Using Size Exclusion Chromatography , 2006 .

[27]  Chaozhan Wang,et al.  High pH Solubilization and Chromatography-Based Renaturation and Purification of Recombinant Human Granulocyte Colony-Stimulating Factor from Inclusion Bodies , 2012, Applied Biochemistry and Biotechnology.

[28]  A. Isetta,et al.  MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. , 1990, Journal of immunological methods.

[29]  Wei-Chiang Shen,et al.  Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Narasu,et al.  A purification method for improving the process yield and quality of recombinant human granulocyte colony‐stimulating factor expressed in Escherichia coli and its characterization , 2008, Biotechnology and applied biochemistry.

[31]  E Schwarz,et al.  Advances in refolding of proteins produced in E. coli. , 1998, Current opinion in biotechnology.

[32]  Chaozhan Wang,et al.  High Recovery Refolding of rhG‐CSF from Escherichia coli, Using Urea Gradient Size Exclusion Chromatography , 2008, Biotechnology progress.

[33]  J. Chaudhuri,et al.  Inclusion body purification and protein refolding using microfiltration and size exclusion chromatography. , 1999, Journal of biotechnology.

[34]  Germán L. Rosano,et al.  Recombinant protein expression in Escherichia coli: advances and challenges , 2014, Front. Microbiol..

[35]  F. Baneyx,et al.  Recombinant protein folding and misfolding in Escherichia coli , 2004, Nature Biotechnology.

[36]  E D Clark,et al.  Protein refolding for industrial processes. , 2001, Current opinion in biotechnology.

[37]  Chi-Ho Lee,et al.  Simplified Large-Scale Refolding, Purification, and Characterization of Recombinant Human Granulocyte-Colony Stimulating Factor in Escherichia coli , 2013, PloS one.